AI-generated summary
In this split-face randomized trial of 35 people with mild-to-moderate acne, the authors compared a 595 nm pulsed dye laser on one side of the face after comedone extraction with the untreated other side. The laser side showed lower erythema index and lower total acne lesion counts at weeks 2 and 4, and the authors describe the treatment as an adjunct with high participant satisfaction and no reported complications.
- Participants
- 35
- Who or what was studied
- Mild-to-moderate acne patients aged 12.9 to 24.2 years
- Wavelengths
- 595 nm
- Limits stated in the abstract
- The abstract does not describe a long-term follow-up beyond week 4, and the authors' conclusion of effectiveness rests on a single small trial.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Comedone extraction provides greater satisfaction for acne treatment than conventional treatment alone; however, post-comedone extraction erythema (PCEE) remains a concern for patients.
Objectives
To evaluate the efficacy of pulsed-dye laser (PDL) in PCEE and comedone reduction.
Methods
Mild-to-moderate acne patients were randomly allocated in split-face fashion. Three comedones were extracted on each facial side. On the PDL-treated side, 595-nm PDL was delivered to the entire side with an additional shot on three comedone-extracted sites. Erythema index (EI) and total acne lesion counts (TALC) were evaluated at baseline, week 2 and 4. The comprehensive acne severity scale (CASS) was assessed by three blinded independent pediatric dermatologists. Participant satisfaction surveys were completed at the end of the study.
Results
Thirty-five participants (age 12.9-24.2 years) showed no differences in the EI and TALC at baseline on both sides. At weeks 2 and 4, the EI on the PDL-treated side was significantly lower (p < 0.001) with a greater EI reduction (p < 0.001) when compared to the control side regardless of gender and menstruation. There was significantly lower TALC on the PDL-treated side at week 2 (p < 0.001) and week 4 (p = 0.02). No complications were noted with high participant satisfaction reported (median 8; IQR 7-9). PDL remained significantly associated with EI improvements after controlling for gender, menstruation cycle, and examination stress.
Conclusion
PDL can be an adjunctive intervention for the treatment of PCEE and comedone reduction due to its effectiveness and high participant satisfaction.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 595 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.